Relating Glucose Clamp Profiles to Reduction of Blood Glucose after Insulin Administration

Diabetes Technology and Therapeutics

Volumn 6, Issue 2, 2004, Pages 147-153

  Woodworth, James R ^a   Howey, Daniel C ^b   Bowsher, Ronald R ^b   Brunelle, Rocco L ^b  

^a VERTEX PHARMACEUTICALS   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; GLUCOSE; INSULIN; INSULIN LISPRO;

ACCURACY; ADULT; ARTICLE; EVALUATION; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HORMONAL REGULATION; HORMONE RESPONSE; HUMAN; HUMAN EXPERIMENT; MALE; MODEL; NORMAL HUMAN; PRIORITY JOURNAL;

BLOOD GLUCOSE; GLUCAGON; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; KINETICS; REFERENCE VALUES;

EID: 1842478374     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/152091504773731339     Document Type: Article

References (14)

1. DeFronzo RA, Binder C, Wahren J, Felig P, Ferrannini E, Faber OK: Sensitivity of insulin secretion to feedback inhibition by hyperinsulinaemia. Acta Endocrinol (Copenh) 1981;98:81-86.
2. Koivisto VA, DeFronzo R, Hendler R, Felig P: The difference in insulin sensitivity and metabolic response to acute exercise in trained and sedentary subjects. Curr Probl Clin Biochem 1982;11:122-132.
3. Ferrannini E, DeFronzo RA, Sherwin RS: Transient hepatic response to glucagon in man: role of insulin and hyperglycemia. Am J Physiol 1982;242:E73-E81.
4. DeFronzo RA, Hendler R, Christensen N: Stimulation of counterregulatory hormonal responses in diabetic man by a fall in glucose concentration. Diabetes 1980;29:125-131.
5. Howey DC, Bowsher RR, Brunelle RL, Woodworth JR: [Lys(B28), Pro(B29)]-human insulin: a rapidly-absorbed analogue of human insulin. Diabetes 1994;43:396402.
6. Heise T, Weyer C, Serwas A, Heinrichs S, Osinga J, Roach P, Woodworth J, Gudat U, Heinemann L: Timeaction profiles of novel premixed preparations of insulin lispro and NPL insulin. Diabetes Care 1998;21:800-803.
7. Heinemann L, Linkeschova R, Rave K, Hompesch B, Sedlak M, Heise T: Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo. Diabetes Care 2000;23:644-649.
8. Heise T, Heinemann L: Rapid and long-acting analogues as an approach to improve insulin therapy: an evidence-based medicine assessment. Curr Pharmaceut Des 2001;7:1303-1326.
9. Heinemann L, Woodworth J: Pharmacokinetics and glucodynamics of insulin lispro. Drugs Today 1998;34(Suppl C):23-36.
10. Urae A, Maeda A, Bowsher RR, Woodworth JR: Safety, pharmacokinetics, and pharmacodynamics of a fast-acting insulin, LY275585, a Phase 1 study-comparison with regular human insulin (Humulin R) [English abstract, article in Japanese]. J Clin Ther Med 2000;16:1601-1611.
11. Woodworth JR, Howey DC, Bowsher RR: Establishment of time-action profiles for regular and NPH insulin using pharmacodynamic modelling. Diabetes Care 1994;17:64-69.
12. Berger M, Cüppers HJ, Hegner H, Jörgens V, Berchtold P: Absorption kinetics and biologic effects of subcutaneously injected insulin preparations. Diabetes Care 1982;5:77-90.
13. Botterman P, Gyaram H, Wahl K, Ermler R, Lebender A: Insulin concentrations and time-action profiles of three different intermediate-acting insulin preparations in nondiabetic volunteers under glucose-controlled glucose infusion technique. Diabetes Care 1982;5(Suppl 2):43-51.
14. Bolli GB, Dimitriadis GD, Pehling GB, Baker BA, Haymond MW, Cryer PE, Gerich JE: Abnormal glucose counterregulation after subcutanous insulin in insulin-dependent diabetes mellitus. N Engl J Med 1984;310:1706-1711.